We have congregated information regarding stocks with the highest payout ratio up to now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Community Bank System, Inc.
54.28% Payout Ratio
Community Bank System, Inc. operates as the bank holding company for Community Bank, N.A. that provides various banking and other financial services to retail, commercial, and municipal customers.
As maintained by Morningstar, Inc., the next dividend payment is on Dec 10, 2020, the estimated forward annual dividend rate is 1.68 and the estimated forward annual dividend yield is 2.6%.
Community Bank System, Inc.'s sales growth this year is expected to be 2.1% and 1.3% for next year.
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 575.88M for the twelve trailing months.
Community Bank System, Inc.'s sales growth is 0.7% for the present ongoing quarter and 1.7% for the next. The company's growth estimates for the current quarter and the next is negative 9.6% and negative -1.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.18%.
Community Bank System, Inc.'s Stock Yearly Top and Bottom Value
Community Bank System, Inc.'s stock is valued at $62.93 at 22:23 EST, way under its 52-week high of $72.63 and way higher than its 52-week low of $47.01.
Community Bank System, Inc.'s Moving Average
Community Bank System, Inc.'s worth is below its 50-day moving average of $63.52 and above its 200-day moving average of $59.10.
2. Ritchie Bros. Auctioneers Incorporated
52.23% Payout Ratio
Ritchie Bros. Auctioneers Incorporated, an asset management and disposition company, sells industrial equipment and other durable assets through its unreserved live on site auctions, online marketplaces, listing services, and private brokerage services.
As stated by Morningstar, Inc., the next dividend payment is on Nov 23, 2020, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 1.29%.
Ritchie Bros. Auctioneers Incorporated's sales growth this year is expected to be 4.6% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 1.33B for the twelve trailing months.
Ritchie Bros. Auctioneers Incorporated's sales growth is 17.2% for the ongoing present quarter and 12.3% for the next. The company's growth estimates for the present quarter and the next is 21.3% and 57.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.14%.
Ritchie Bros. Auctioneers Incorporated's Stock Yearly Top and Bottom Value
Ritchie Bros. Auctioneers Incorporated's stock is valued at $68.14 at 22:23 EST, way under its 52-week high of $78.64 and way higher than its 52-week low of $25.92.
Ritchie Bros. Auctioneers Incorporated's Moving Average
Ritchie Bros. Auctioneers Incorporated's value is above its 50-day moving average of $67.85 and way higher than its 200-day moving average of $56.25.
3. Universal Health Realty Income Trust
187.07% Payout Ratio
Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers.
As maintained by Morningstar, Inc., the next dividend payment is on Dec 15, 2020, the estimated forward annual dividend rate is 2.78 and the estimated forward annual dividend yield is 4.1%.
Universal Health Realty Income Trust's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 78.87M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.69%.
Universal Health Realty Income Trust's Stock Yearly Top and Bottom Value
Universal Health Realty Income Trust's stock is valued at $65.90 at 22:23 EST, way under its 52-week high of $132.41 and way above its 52-week low of $52.25.
Universal Health Realty Income Trust's Moving Average
Universal Health Realty Income Trust's worth is higher than its 50-day moving average of $62.49 and under its 200-day moving average of $67.42.
4. Medical Properties Trust, Inc.
121.59% Payout Ratio
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.
As maintained by Morningstar, Inc., the next dividend payment is on Dec 8, 2020, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 5.12%.
Medical Properties Trust, Inc.'s sales growth this year is expected to be 45.7% and 11.6% for next year.
Year-on-year quarterly revenue growth grew by 46.9%, now sitting on 1.19B for the twelve trailing months.
Medical Properties Trust, Inc.'s sales growth is 29% for the present ongoing quarter and 10% for the next. The company's growth estimates for the current quarter and the next is 3.8% and 73.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.85%.
Medical Properties Trust, Inc.'s Stock Yearly Top and Bottom Value
Medical Properties Trust, Inc.'s stock is valued at $21.08 at 22:23 EST, way below its 52-week high of $24.29 and way higher than its 52-week low of $12.35.
Medical Properties Trust, Inc.'s Moving Average
Medical Properties Trust, Inc.'s value is higher than its 50-day moving average of $19.82 and way higher than its 200-day moving average of $18.94.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
